VRSN(VRSN)
VRSN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.75B | $1.92B | $2.08B |
| Low | $1.73B | $1.89B | $2.05B |
| High | $1.76B | $1.93B | $2.12B |
| EBITDA Avg | $1.29B | $1.42B | $1.54B |
| Low | $1.28B | $1.39B | $1.51B |
| High | $1.30B | $1.42B | $1.56B |
| EBIT Avg | $1.29B | $1.41B | $1.53B |
| Low | $1.28B | $1.39B | $1.51B |
| High | $1.30B | $1.42B | $1.56B |
| Net Income Avg | $907M | $1.02B | $1.17B |
| Low | $904M | $1.01B | $1.16B |
| High | $910M | $1.04B | $1.19B |
| EPS Avg | $9.79 | $11.09 | $12.61 |
| Low | $9.76 | $10.91 | $12.47 |
| High | $9.83 | $11.22 | $12.86 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 4 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $440M | $449M | $465M | $478M | $491M | $498M |
| Low | $437M | $449M | $463M | $475M | $489M | $496M |
| High | $443M | $449M | $467M | $480M | $493M | $501M |
| EBITDA Avg | $324M | $331M | $343M | $352M | $362M | $367M |
| Low | $322M | $331M | $341M | $350M | $360M | $365M |
| High | $327M | $331M | $344M | $354M | $363M | $369M |
| EBIT Avg | $324M | $330M | $342M | $351M | $361M | $367M |
| Low | $322M | $330M | $340M | $350M | $359M | $365M |
| High | $326M | $331M | $344M | $353M | $363M | $368M |
| Net Income Avg | $224M | $229M | $242M | $250M | $256M | $261M |
| Low | $223M | $228M | $240M | $249M | $255M | $259M |
| High | $225M | $230M | $243M | $252M | $258M | $262M |
| EPS Avg | $2.46 | $2.51 | $2.65 | $2.75 | $2.81 | $2.86 |
| Low | $2.45 | $2.50 | $2.64 | $2.73 | $2.79 | $2.84 |
| High | $2.47 | $2.52 | $2.67 | $2.76 | $2.83 | $2.88 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |